Two experiments were conducted to study effects of cloprostenol sodium (cloprostenol) and clenbuterol HCl (clenbuterol) during postpartum anestrus on subsequent reproductive performance in cows. In Experiment I, 96 cows received either 0.5 mg cloprostenol (PGF, n = 25), 364 mg clenbuterol (CLEN, n = 24), 0.5 mg cloprostenol and 364 mg clenbuterol (CLEN+PGF, n = 21) or no treatment (Control, n = 26) on Day 20 post partum. Treatments failed to influence postpartum interval, pregnancy rate or the incidence of short estrous cycles preceding the first normal estrous cycle. In Experiment II, anestrous cows were administered cloprostenol (0.5 mg) on either Day 20 (PGF20, n = 27) or Day 35 post partum (PGF35, n = 25), or served as untreated controls (Control, n = 26). Neither postpartum interval nor pregnancy rate were affected by cloprostenol treatment. In conclusion, treatment of postpartum cows with PGF did not alter the resumption of normal estrous cycles following parturition.

Journal Article↗

PubMed1990

Regulation of luteinizing hormone secretion in prepubertal heifers fed an energy-deficient diet.

The effects of feeding a diet restricted in energy on the endocrine mechanisms regulating LH secretion in prepubertal heifers were examined. On Day 0, thirty heifers were assigned to be either ovariectomized (OVX; n = 10), ovariectomized and administered an estradiol implant (OVXE; n = 10), or to remain ovary-intact (INT, n = 10). Five heifers each were then assigned to be fed either a control (C) or a two-phase, low-to-high energy (L), dietary treatment. The C diet was formulated to support weight gains of 1.1 kg/day throughout the experiment (Day 0-197). Heifers receiving the L treatment were provided a diet restricted in energy (33% of C diet) from Day 0-127 followed by a diet similar to that fed to heifers receiving the C treatment from Day 128-197. Secretion of LH increased rapidly following ovariectomy in C-OVX and L-OVX heifers. During the period of energy restriction, LH pulse frequency was reduced, and mean LH concentration, pulse amplitude, and pituitary response to LHRH were greater in L-OVX than in C-OVX heifers. In L-OVXE and L-INT heifers, secretion of LH was low and unchanged during the period of dietary energy restriction. In contemporaneous treatment groups fed the C diet (C-OVXE and C-INT), frequency of LH pulses increased gradually during this period and C-INT heifers attained puberty on Day 121 +/- 18. Upon switching heifers in the L-OVX, L-OVXE, and L-INT treatments to the C diet, all characteristics of LH secretion changed markedly within 14 days to levels similar to those detected in the C treatments.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

PubMed1990

[Social factors and mortality in Taiwan: analysis of six causes of death in small areas].

Explore the source record for details and available documents.

Asia↗

PubMed1990

[Studies on the toxicity of a new synthetic drug SC1001-aminum].

SC1001A is a new sedative, hypnotic and anti-epileptic drug. Screening for possible mutagenicity of the agent consisted of a battery scheme of short-term mutagenic tests with different hereditary detecting end points. Three assays were with in the scheme: Ames test (for detecting gene mutation in vitro), micronucleus test (for detecting chromosomal aberration in vivo) and CHL (Chinese hamster lung cell line) test (for detecting chromosomal aberration in vitro). In addition, a routine teratogenicity study on SC1001A was carried out in mice. They were given daily at 3-dose levels (exposed to up to 33% of the LD50 by gastric incubation from the 6th through the 15th day of gestation. SC1001A gave uniformly negative results in all three mutagenic assay systems. Results of the teratogenic experiment showed that only the pregnant rate in bred mice in the moderate dose group and the mean maternal body weight gain of the dams during gestation in the low dose group were significantly lower than those in the corresponding control group. A clear dose-response relationship was not demonstrated. All dose levels of SC1001A used caused no adverse effects on the number of survival fetuses per litter, growth or development of the fetal mice. No malformations in the external appearance, of the internal organs and of the skeletal systems in fetal mice were observed. The above-mentioned results indicated that SC1001A induced neither gene mutation nor chromosomal damage both in vitro and in vivo. There was no evidence of teratogenesis. Therefore, it is estimated that SC1001A is probably comparatively safe as a pharmaceutical product for human beings in usual dosage.

Animals↗

PubMed1990

[Preparation, identification and functional studies on liposome (ApoA-I:PC)].

Liposome (ApoA-1: PC) was prepared by the deoxycholic acid dialysis method and identified by agarose gel electrophoresis, two dimensional thin-layer chromatography and electron microscopy. The purified liposomes manifested one band in Amino black 10B staining and no color in Oil red O staining due to the presence of phospholipid. Only one brown spot appeared in two dimensional TLC, and electron microscopy with 1% sodium phosphotungstate negative staining revealed discoidal shapes stuck together. All of the above indicate that the liposome consisted of ApoA-1 and PC. Liposomes were added to the medium of smooth muscle cell cultures and then LDL receptor expression and cholesterol efflux from the cells were observed. The results suggest that the ApoA-1:PC can enhance the expression of LDL receptors indirectly by stimulating cholesterol efflux from the cells.

Animals↗

PubMed1990

[An epidemiological survey of gallstones with gray-scale ultrasound].

Gray-scale real-time ultrasound has been employed to investigate gallstone with a positive result of 553 cases out of 15,856 healthy subjects in city and countryside, the incidence being 34.88%. The feature of incidence is as follows: 1. The incidence of the simple gallbladder stone is more common than that of the other sites (male is about 81.15%, female is about 87.29%); 2. The incidence of gallstones of city residents is higher than that of the country people with significant difference statistically (P less than 0.01); 3. The incidence of gallstone in female city residents is higher than male, about 2.5:1, which shows significant difference. (P less than 0.01); 4. The incidence of gallstones in female city residents is higher than in countryside (P less than 0.01); 5. There is no significant difference in the incidence of gallstone between male and female in the countryside (P greater than 0.05); 6. There is no significant difference in the incidence of gallstones between city male and the male in the countryside (P greater than 0.05); 7. Either in the city or in the countryside, it has been shown that there is a tendency of increasing incidence of gallstone with age in both sexes (P less than 0.01). The relationship between the gallstone and the clinical symptoms has been discussed in this paper.

Adolescent↗

PubMed1990

[Nursing care after thymus transplantation in patients with advanced liver cancer].

Explore the source record for details and available documents.

Adult↗

PubMed1990

Effects of purified compound (8501) on hyperlipidemia and the balance between thromboxane A2 and prostacyclin in rabbits.

New Zealand strain white male rabbits were divided into four groups to study the effects of 8501, extracted from a Chinese herb, on hyperlipidemia and the TXA2/PGI2 ratio in atherosclerotic rabbits. The results indicate that serum cholesterol and the levels of cholesterol and cholesteryl ester in aortic tissue were significantly increased in cholesterol-fed rabbits. The percentage of alpha-lipoprotein was significantly decreased and the aortic atherosclerotic plaque area was significantly increased. The data also demonstrate that the level of plasma TXB2 was markedly increased, while that of 6-keto-PGF1 alpha was significantly decreased. The TXB2/6-keto-PGF1 alpha ratio (T/6) was significantly increased. The decrease of 6-keto-PGF1 alpha occurred prior to the increase of TXB2. Compound 8501 not only lowered serum total cholesterol and aortic total cholesterol and cholesteryl ester but also antagonized the decrease of alpha-lipoprotein and atherosclerotic plaque formation. In addition, 8501 prevented the decrease of plasma 6-keto-PGF1 alpha and the increase of TXB2, and so the T/6 ratio was significantly decreased.

6-Ketoprostaglandin F1 alpha↗

PubMed1989